Otitis Media: Treatment with Intranasal Aerosolized Surfactant

Laryngoscope

Volumn 114, Issue 3, 2004, Pages 472-485

  Chandrasekhar, Sujana S ^a   Mautone, Alan J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Eustachian tube function; Eustachian tube passive opening pressure; Otitis media surfactant intranasal therapy

Indexed keywords

BETAMETHASONE; LIPOPOLYSACCHARIDE; PHENYLEPHRINE; PLACEBO; SURFACTANT;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY TUBE; CONTROLLED STUDY; GERBIL; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; METERED DOSE INHALER; MOUSE; NONHUMAN; OTITIS MEDIA; OTOSCOPY; PRIORITY JOURNAL; RANDOMIZATION; SECRETORY OTITIS MEDIA; STATISTICAL ANALYSIS; TYMPANOMETRY;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; AEROSOLS; ANALYSIS OF VARIANCE; ANIMALS; CHI-SQUARE DISTRIBUTION; DISEASE MODELS, ANIMAL; GERBILLINAE; MALE; MICE; NEBULIZERS AND VAPORIZERS; OTITIS MEDIA; OTITIS MEDIA WITH EFFUSION; PRESSURE; SURFACE-ACTIVE AGENTS;

EID: 1642411462     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200403000-00017     Document Type: Article

References (63)

1. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg 1996;114:525-530.
2. Bauchner H, Pelton SI, Klein JO. Parents, physicians and antibiotic use. Pediatrics 1999;103:395-401.
3. Bluestone CD. Eustachian tube function: physiology, pathophysiology and role of allergy in pathogenesis of otitis media. J Allergy Clin Immunol 1983;72:242-251.
4. Sando I, Takahashi H, Matsune S, Aoki H. Localization of function in the eustachian tube: a hypothesis. Ann Otol Rhinol Laryngol 1994;103:311-314.
5. Alper CM, Andalibi A, Bakaletz LO, et al. Recent advances in otitis media. 4. Anatomy, cell biology, pathology and animal models. Ann Otol Rhinol Laryngol Suppl 2002;188:36-51.
6. Flisberg K, Ingelstedt S, Ortegren V. The valve and locking mechanism of the eustachian tube. Acta Otolaryngol Suppl (Stockh) 1963;182:57-68.
7. Bluestone CD, Klein JO. Otitis Media in Infants and Children. Philadelphia: WB Saunders; 1995:192-197.
8. Reidpath DD, Glasziou PP, Del Mar C. Systematic review of autoinflation for treatment of glue ear in children. BMJ 1999;318:1177.
9. Spratley J, Hellstrom S, Eriksson P-O, Pais-Clemente M. Myringotomy delays the tympanic membrane recovery in acute otitis media: a study in the rat model. Laryngoscope 2002;112:1474-1481.
10. Rapport PN, Lim DJ. Surface active agent in eustachian tube function. Arch Otolaryngol 1975;101:305-311.
11. Birken EA, Brookler KH. Surface tension lowering substance of the canine eustachian tube. Am J Otol 1972;81:268-271.
12. Grace A, Kwok P, Hawke M. Surfactant in middle ear effusions. Otolaryngol Head Neck Surg 1987;96:336-340.
13. Hills BA. Analysis of eustachian surfactant and its function as a release agent. Arch Otolaryngol 1984;110:3-9.
14. White P, Hermansson A, Svinhfvud M. Surfactant and isoprenaline effect on eustachian tube opening in rats with acute otitis media. Am J Otolaryngol 1990;11:389-392.
15. Passali D, Zavattini G. Multicenter study on the treatment of secretory otitis media with Ambroxol: importance of a surface-tension-lowering substance. Respiration 1987;51:52-59.
16. Kobayashi T, Yaginuma Y, Toshima M, et al. Use of surfactants in the treatment of secretory otitis media: a preliminary report. In: Lim DJ, Bluestone CD, eds. Recent Advances in Otitis Media: Proceedings of the Fifth International Symposium. Hamilton, Ontario, Canada: Decker Periodicals; 1993:286-288.
17. Nemechek AJ, Pahlavan N, Cote DN. Nebulized surfactant for experimentally induced otitis media with effusion. Otolaryngol Head Neck Surg 1997;117:475-479.
18. Koten M, Uzun C, Yagiz R, et al. Nebulized surfactant as a treatment choice for otitis media with effusion: an experimental study in the rabbit. J Laryngol Otol 2001;115:363-368.
19. Scarpelli EM, et al. Aerosolization of surfactant and subsequent development of an aerosol vehicle for delivery of medications to the lung. In: International Symposium on Perinatal Medicine and Human Reproduction. Rome, Italy: Monduzzi Editore, 1995.
20. Nevado JA, Davidson ML, Skurnick JH, Mautone AJ. Effective synthetic surfactant aerosol via metered dose inhaler (MDI) in an acute lung injury model [abstract]. In: The American Pediatric Society/The Society for Pediatric Research, 1998.
21. Caballes-Ponce JG, Davidson ML, Skurnick JH, Mautone AJ. Effect of epinephrine delivered endotracheally in a surfactant based aerosol via metered dose inhaler (MDI) compared to instillation in normal and shock rabbit models. [abstract]. In: The American Pediatric Society/The Society for Pediatric Research, 1998.
22. Mautone AJ. Phospholipid delivery system. U.S Pat. No. 5174988 issued December 29, 1992; U.S. Pat. No. 5306483 issued April 26, 1994. US Patent Office, Washington, DC.
23. Pelton SI. Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2002;21:599-604.
24. Bluestone CD, Klein JO. Otitis Media in Infants and Children. Philadelphia: WB Saunders; 1995:55-63, 148.
25. Chandrasekhar SS, Connelly PE, Venkatayan N, Ammar Me S, Tabor M, Mautone AJ. Intranasal metered dose aerosolized surfactant reduces passive opening pressure of the eustachian tube: comparison study in two animal models. Otol Neurotol 2002;23:3-7.
26. Fulghum RS, Hoogmoed RP, Brinn JE. Longitudinal studies of experimental otitis media with Hemophilus influenzae on the gerbil. Int J Pediatr Otorhinol 1985;9:101-114.
27. Venkatayan N, Troublefield YL, Connelly PE, Mautone AJ, Chandrasekhar SS. Intranasal surfactant aerosol therapy for otitis media with effusion. Laryngoscope 2000;110:1857-1860.
28. Venkatayan N, Connelly PE, Mautone AJ, Troublefield YL, Chandrasekhar SS. Dosage regimens of intranasal aerosolized surfactant on otitis media with effusion in an animal model. Otolaryngol Head Neck Surg 2001;124:388-393.
29. Pitkara A, Virolainen A, Jero J, et al. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998;102:291-295.
30. Moody SA, Alper CM, Doyle WJ. Daily tympanometry in children during the cold season: association of otitis media with upper respiratory tract infections. Int J Pediatr Otorhinolaryngol 1998;45:143-150.
31. Ogra PL, Barenkamp SJ, DeMaria TF, et al. Microbiology and immunology. In: Lim DJ, ed. Recent Advances in Otitis Media. Ann Otol Rhinol Laryngol 2002;111:62-81.
32. Doyle WJ, Alper CM, Bluestone CD, et al. Middle ear physiology and pathophysiology. In: Lim DJ, ed. Recent Advances in Otitis Media. Ann Otol Rhinol Laryngol 2002;111:26-35.
33. Jung TTK, Rhee CK. Otolaryngologic approach to the diagnosis and management of otitis media. Otolaryngol Clin North Am 1991;24:931-945.
34. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002;287:3096-3102.
35. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 2002;287:3103-3109.
36. Straetemans S, Sanders EA, Veenhoven RH, et al. Pneumococcal vaccines for preventing otitis media. Cochrane Database Syst Rev 2002;2:CD001480.
37. Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002;35:168-174.
38. Park S-N, Yeo SW. Effects of antibiotics and steroid on middle ear mucosa in rats with experimental acute otitis media. Acta Otolaryngol 2001;121:808-812.
39. Herman P, Tan C-T, Abbeele VD, et al. Glucocorticosteroids increase sodium transport in middle ear epithelium. Am J Physiol 1997;272:C184-C190.
40. Tan C-T, Escoubet B, Abbeele VD, et al. Modulation of middle ear epithelial function by steroids: clinical relevance. Acta Otolaryngol (Stockh) 1997;117:284-288.
41. Bluestone CD, Klein JO, Rosenfeld RM, et al. treatment, complications and sequelae. In Lim DJ, ed. Recent Advances in Otitis Media. Ann Otol Rhinol Laryngol 2002;111:102-124.
42. Bluestone CD, Klein JO. Otitis Media in Infants and Children. Philadelphia: WB Saunders; 1995:192-197.
43. Ruohola A, Heikkinen T, Waris M, Puhakka T, Ruuskanen O. Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children. J Allergy Clin Immunol 2000;106:467-471.
44. Tracy JM, Demain JG, Hoffman KM, Goetz DW. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Ann Allergy Asthma Immunol 1998;80:198-206.
45. Butler CC, van Der Voort JH. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2000;4: CD0019935.
46. Schwartz RH, Schwartz DM, Grundfast KM. Intranasal beclomethasone in the treatment of middle ear effusion: a pilot study. Ann Allergy 1980;45:284-287.
47. Lecks HI, Kravis LP, Wood DW. Serous otitis media: reflections on pathogenesis and treatment. Clin Pediatr 1967;6:519-523.
48. Macknin ML. Editorial, Steroid treatment for otitis media effusion. Clin Pediatr 1991;30:178-182.
49. Shapiro GG, Bierman CW, Furukawa CT, et al. Treatment of persistent Eustachian tube dysfunction in children with aerosolized nasal dexamethasone phosphate versus placebo. Ann Allergy 1982;49:81-85.
50. Turner RB, Darden PM. Effect of topical adrenergic decongestants on middle ear pressure in infants with common colds. Pediatr Infect Dis J 1996;15:621-624.
51. Arick DS, Silman S. Treatment of otitis media with effusion based on politzerization with an automated device. Ear Nose Throat J 2000:290-298.
52. Stangerup S-E, Tjernstrom O, Harcourt J, Klokker M, Stokholm J. Barotitis in children after aviation: prevalence and treatment with Otovent. J Laryngol Otol 1996;110:625-628.
53. Gottschalk GH. Nonsurgical management of otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1980;89(3, pt 2):301-302.
54. Van Heerbeek N, Ingels KJAO, Rijkers GT, Zielhuis GA. Therapeutic improvement of eustachian tube function: a review. Clin Otolaryngol 2002;27:50-56.
55. Lim DJ, Chun YM, Lee SK, et al. Cell biology of tubotympanum in relation to pathogenesis of otitis media: a review. Vaccine 2001;19:S17-S25.
56. Clark JC, Weaver TE, Iwamoto HS, et al. Decreased lung compliance and air-trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol 1997;16:46-52.
57. Paananen F, Sormunen R, Glumoff V, Van Eijk M, Hallman M. Surfactant proteins A and D in eustachian tube epithelium. Am J Physiol Lung Cell Mol Physiol 2001;281: L660-L667.
58. Ramet M, Lofgren J, Alho OP, Hallman M. Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr 2001:138:266-268.
59. White P. Effect of exogenous surfactant on eustachian tube function in the rat. Am J Otolaryngol 1989;10:301-304.
60. Fornadley JA, Burns JK. The effect of surfactant on eustachian tube function in a gerbil model of otitis media with effusion. Otolaryngol Head Neck Surg 1994;110:110-114.
61. Suh SH, Chon KM, Min YG, Jeong CH, Hong SL. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits. Acta Otolaryngol 1995;115:664-671.
62. Min YG, Kim HS, Suh SH, et al. Paranasal sinusitis after long-term use of topical nasal decongestants. Acta Otolaryngol 1996;116:465-471.
63. Meyerhoff WL, Shea DA, Giebink GS. Experimental pneumococcal otitis media: a histologic study. Otolaryngol Head Neck Surg 1980;88:606-612.